Skip to main navigation Skip to search Skip to main content

An International Phase 2-3, Stratified, Randomized, Open-Label, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients...

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/04 → 5/31/07

Funding

  • Aventis Pharmaceuticals Products Inc: $14,570.00